Activity of angiogenesis inhibitors in metastatic epithelioid hemangioendothelioma: a case report

Sumit Gaur; Alireza Torabi; T. J. O'Neill

doi:10.3969/j.issn.2095-3941.2012.02.010

Activity of angiogenesis inhibitors in metastatic epithelioid hemangioendothelioma: a case report

Sumit Gaur, Alireza Torabi, T. J. O'Neill

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Abstract

This report describes a patient with metastatic epithelioid hemangioendothelioma treated with bevacizumab and nanoparticle albumin-bound paclitaxel. The treatment was well tolerated and led to the stabilization of an aggressive variant of the disease. This case report is the first one that describes the activity of the combination of chemotherapy and bevacizumab in epithelioid hemangioendothelioma. Literature describing the activity of bevacizumab and other agents (thalidomide, lenalidomide, and interferon) believed to possess anti-angiogenic activities is also reviewed.

Original language	English (US)
Pages (from-to)	133-136
Number of pages	4
Journal	Cancer Biology and Medicine
Volume	9
Issue number	2
DOIs	https://doi.org/10.3969/j.issn.2095-3941.2012.02.010
State	Published - Jun 2012
Externally published	Yes

Keywords

Angiogenesis inhibitors
Bevacizumab
Hemangioendothelioma
Nab-paclitaxel

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.3969/j.issn.2095-3941.2012.02.010

Cite this

@article{48987493053448d4bfaebff1e5257042,

title = "Activity of angiogenesis inhibitors in metastatic epithelioid hemangioendothelioma: a case report",

abstract = "This report describes a patient with metastatic epithelioid hemangioendothelioma treated with bevacizumab and nanoparticle albumin-bound paclitaxel. The treatment was well tolerated and led to the stabilization of an aggressive variant of the disease. This case report is the first one that describes the activity of the combination of chemotherapy and bevacizumab in epithelioid hemangioendothelioma. Literature describing the activity of bevacizumab and other agents (thalidomide, lenalidomide, and interferon) believed to possess anti-angiogenic activities is also reviewed.",

keywords = "Angiogenesis inhibitors, Bevacizumab, Hemangioendothelioma, Nab-paclitaxel",

author = "Sumit Gaur and Alireza Torabi and O'Neill, {T. J.}",

year = "2012",

month = jun,

doi = "10.3969/j.issn.2095-3941.2012.02.010",

language = "English (US)",

volume = "9",

pages = "133--136",

journal = "Cancer Biology and Medicine",

issn = "2095-3941",

publisher = "Chinese Anticancer Association",

number = "2",

}

TY - JOUR

T1 - Activity of angiogenesis inhibitors in metastatic epithelioid hemangioendothelioma

T2 - a case report

AU - Gaur, Sumit

AU - Torabi, Alireza

AU - O'Neill, T. J.

PY - 2012/6

Y1 - 2012/6

N2 - This report describes a patient with metastatic epithelioid hemangioendothelioma treated with bevacizumab and nanoparticle albumin-bound paclitaxel. The treatment was well tolerated and led to the stabilization of an aggressive variant of the disease. This case report is the first one that describes the activity of the combination of chemotherapy and bevacizumab in epithelioid hemangioendothelioma. Literature describing the activity of bevacizumab and other agents (thalidomide, lenalidomide, and interferon) believed to possess anti-angiogenic activities is also reviewed.

AB - This report describes a patient with metastatic epithelioid hemangioendothelioma treated with bevacizumab and nanoparticle albumin-bound paclitaxel. The treatment was well tolerated and led to the stabilization of an aggressive variant of the disease. This case report is the first one that describes the activity of the combination of chemotherapy and bevacizumab in epithelioid hemangioendothelioma. Literature describing the activity of bevacizumab and other agents (thalidomide, lenalidomide, and interferon) believed to possess anti-angiogenic activities is also reviewed.

KW - Angiogenesis inhibitors

KW - Bevacizumab

KW - Hemangioendothelioma

KW - Nab-paclitaxel

UR - http://www.scopus.com/inward/record.url?scp=84876301773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876301773&partnerID=8YFLogxK

U2 - 10.3969/j.issn.2095-3941.2012.02.010

DO - 10.3969/j.issn.2095-3941.2012.02.010

M3 - Article

C2 - 23691469

AN - SCOPUS:84876301773

SN - 2095-3941

VL - 9

SP - 133

EP - 136

JO - Cancer Biology and Medicine

JF - Cancer Biology and Medicine

IS - 2

ER -

Activity of angiogenesis inhibitors in metastatic epithelioid hemangioendothelioma: a case report

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this